The prevalance of hyperlipidemia in type 2 diabetes, diabetic cardiomyopathy and/or diabetic kidney disease

This is an automatically generated default intro template – please do not edit.

	Read full article
Article Title:	The prevalance of hyperlipidemia in type 2 diabetes, diabetic cardiomyopathy and/or diabetic kidney disease
Authors:	Mădălina Mihuţ (Moca), Annamaria Pallag, Luisa Demian, Aurel Petru Babeş
Affiliation:	University of Oradea, Faculty of Medicine and Farmacy Departement of Internal Medicine II – Diabetes, Nutrition and Metabolic Syndromes University of Oradea, Faculty of Medicine and Farmacy Departement of Pharmacy
Abstract:
Keywords:
References:	Şerban V. Tratat român de boli metabolice 1 – Timişoara: Brumar 2010, ISBN 978-973- 602-527-3; 2010 Barroso I. Genetics of Type 2 diabetes. Diabet Med; 22: 517-535, 2005 Grigorescu F., Attaoua R., Ait El Mkadem S., Radian Ş., Susceptibility genes for insulin resistance and type 2 diabetes. In Cheţa D(ed). Genetics of diabetes. The Truth Unveiled. Ed. Acad. Rom, Bucureşti&S. Krager AG, Basel; 131-192, 2010 Gerich J.E., Smith T.S. Beta-cell defects and abnormalities in type 2 diabetes. In: Pikup J.C., Wiliams G. (eds). Textbook of Diabetes, Third Edition. Blackwell Science Ltd., Oxford, 2003: 23.1-23.11, 2003. Utzschneider K., Kahn S.E., Beta-cell disfunction in type 2 diabetes. IN: DeFronzo R.A., Ferrannini E., Keen H., Zimmet P., (eds). International Textbook of Diabetes Mellitus, Third Edition, John Wiley&Sons, Ltd. Chichester: 375-388, 2004. Ionescu-Tîrgovişte C., Lichiardopol R., Guja C. Diabetul Zaharat: Manual pentru studenţi, medici de familie şi rezidenţi. Bucureşti: Editura Ilex. ISBN 978-973-7928- 16-0: 55-114. Krentz A.J. Fortnightly Review: Insulin resistance, BMJ 1996; 313: 1385-1389, 2007. Pan D.A., Lilioja S., Kriketos, A.D. et. al. Skeletal muscle triglyceride levels are inversely related to insulin action; Diabetes, 46: 983-988, 1997. Bala C., Fodor A., Hâncu N. Diabetul zaharat, nutriţia, bolile metabolice : curs pentru studenţi. Editura Medicală Universitară „Iuliu Haţieganu” Cluj-Napoca; ISBN 978-973-693-334-9: 32-108, 2009. DeFronzo RA, Mandarino L, Ferrannini E. Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus. In: DeFronzo RA, Ferrannini E, Keen H, P Zimmet, editors. International Textbook of Diabetes Mellitus. 4rd ed. Chichester: John Wiley; 2009. Şerban V. Tratat român de boli metabolice 2 – Timişoara: Brumar 2011, ISBN 978-973- 602-554-9, 2011. Nathan D.M, Buse J.B, Davidson M.B, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 32(1): 193-203, 2009. DavidsonMH. Global Risk Management in Patients with Type 2 Diabetes Mellitus. Am JCardiol; 99 41B-50B, 2007. Rutter MK, Meigs JB, Wilson PWF. Cardiovascular Risk and the Metabolic syndrome, Metabolic Syndrome and Related Disorders; 4:252-60, 2006. Ahmad L.A., Crandall J.P. Type 2 Diabetes Prevention: A Review. Clin Diabetes; 28: 53-59, 2010. Moşuţan C., Diaconu R.E., Rădulescu M.L., Şerban A.M., Duncea C.R., Risk factors for post-acute myocardial infarction depression in elderly. Human and Veterinary Medicine 3(3):220-226, 2011. Martin Silink and Jean-Claude Mbanya. Global standardization of the HbA1c assay – the consensus committee recommendations; International Diabetes Federation; Diabetes Voice; Volume 52, Issue 4, 2007: 33-34.
*Correspondence:	Mihuț (Moca) Mădălina, Universitatea din Oradea, Facultatea de Medicină și Farmacie Oradea, Str. 1 Decembrie Nr. 10, nr. de tel: 0259415680, email: missy_madalina@yahoo.com